By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Constellation Pharmaceuticals 

215 First Street
Suite 200
Cambridge  Massachusetts  02142  U.S.A.
Phone: 617-714-0555 Fax: 617-859-2891


SEARCH JOBS



Key Statistics


Email:
Ownership: Private

Web Site: Constellation Pharma
Employees:
Symbol: 
 




Segment
Start Up





Company News
Constellation Pharma Mulls IPO After Genentech (RHHBY) Declines to Buy 8/25/2015 6:25:12 AM
Constellation Pharmaceuticals Initiates Clinical Development Of CPI-1205, A Novel Inhibitor Of EZH2, In Patients With Lymphoma 4/28/2015 8:36:32 AM
Constellation Pharmaceuticals Quietly Cuts 23 Employees as Genentech (RHHBY)'s Decision Looms 1/19/2015 6:25:09 AM
Constellation Pharmaceuticals and the University of Pittsburgh School of Medicine Receive Cystic Fibrosis Foundation Research Grant 10/10/2013 9:36:10 AM
Constellation Pharmaceuticals Announces New Preclinical Data on Novel BET Bromodomain Inhibitors Published in The Journal of Experimental Medicine 10/8/2013 10:38:19 AM
Constellation Pharmaceuticals Initiates Clinical Development of CPI-0610, a Novel BET Protein Bromodomain Inhibitor, in Patients With Lymphoma 9/10/2013 9:32:50 AM
Constellation Pharmaceuticals and The Leukemia & Lymphoma Society Partner to Develop Novel BET Inhibitor for the Treatment of Hematologic Malignancies 9/20/2012 10:22:54 AM
Constellation Pharmaceuticals Appoints Keith E. Dionne, Ph.D., as Chief Executive Officer 3/27/2012 6:52:54 AM
Genentech (RHHBY) Pours $95 Million into Constellation Pharmaceuticals Epigenetic Drug Platform, Deal Includes M&A Terms 1/17/2012 6:55:55 AM
Constellation Pharmaceuticals Raises $15 Million in Additional Funding 6/6/2011 6:34:59 AM
12
//-->